Glutathione S-transferase, alterations 146 Goiter multinodular 210
|
|
- Erik Bridges
- 5 years ago
- Views:
Transcription
1 Subject Index A Ablation (see also radioiodine ablation) - follow-up intervals after successful 174 Aclarubicin 140 Adenomatous polyposis, familial 58, 59 Adenovirus, p53-expressing 147 Adrenalectomy 292 Age 229 Age-standardized rates (of incidence I mortality) 4 AJCC (American Joint Committee on Cancer) 5, 11 American Joint Committee on Cancer (AJCC) 5, 11 Amifostine 113 Amyloid 240 Anaplastic thyroid cancer 6, 8-10, 13, 14, 18,20 Angiogenesis 145 Antiproliferative effects 160 Apoptosis 145, control 147 Artifacts of imaging 169 Ataxia-teleangiectasia 58 Atrophy, salivary gland 220 Autopsy studies 4, 6, 8, 11 B Belarus, relative incidence - adults children 227 Biochemical screening 245, 246 Biopsy smear 46 Bladder cancer 116 Bleomycin Bone - marrow ll5 - postmenopausal women scanning 256 ( C cells 239 CA Calcitonin (CT) 239,251, 276, 287 Cancer registry 3, 4, 6, 15, 16, 20 Cancer risk - children and adolescence external irradiation radioiodine 225 Carcinoembryonic antigen (CEA) 241,244, 251,279,287 Carcinoma - anaplastic 31 - follicular 31 - medullary 31 - papillary 31 Cardiac pacemakers 199 C-cell carcinoma of the thyroid - in children and teenagers 14 - frequencyof8, 9,14 - prognosis of 9, 10, 14 C-cell hyperplasia 240, diffuse 245 CEA (carcinoembryonic antigen) 241, 244, 251,279,287 Cell adhesion molecules 156 Cell cycle regulation 43 - clonality 44 - telomerase 45 Cervicocentral compartment 278 Cervicolateral compartment 278 Chemotherapy 111, 176,282 - protocols 148 Chernobyl accident 226 Chernobyl nuclear power plant accident 17 Childhood and adolescence 8, 9, 14, 17 Childhood thyroid cancer, multicenter studies 231 Cholecystokinin-B/gastrin receptor scintigraphy 266
2 296 Subject Index 13-cis retinoic acid 157 Cisplatin 140, 141, 142 C-met 59 Coils 194 Color-Doppler 71-3D-display 73 Combination chemotherapy 144 Completion thyroidectomy 87 Computed tomography 256 Conception 115 Cowden's syndrome 58 Crude rates (of incidence I mortality) 4 CT 77 - concentration 241 -measurement 240,241,243 - tumor marker 240 Cyclophosphamide 143, 144 Cytotoxic drugs resistance treatment 139 D Dedifferentiation iodide accumulation 154 Deiodinase 155 Diagnostic protocol 230 Diet, low-iodine 109 Differentiated thyroid cancer 132, 148 Differentiated thyroid carcinoma 82, 83, 121, radiosensitivity 122 Disease, recurrent 87 DNA topoisomerase 146 Dose response 231 Doxorubicin monotherapy 148 E E-cadherin 156 Echo time 195 Edema - cerebral painless neck 112 Electromagnetic impulse 194 Epidemiological data 84, 227 Epidemiological studies - external irradiation Epidemiology - basic methodological problems of 3 - changesin Ethnic groups 56 EUROCARE database 9, 19 Evaluation - postoperative presurgical 185 External radiotherapy adjuvant radiotherapy in anaplastic carcinoma in differentiated thyroid carcinoma Freiburger consensus indications for metastases prospective trial radiosensitivity of DTC retrospective studies 124 ff. - side effects treatment protocols 124 Extrathyroid tumor extension 85 F Familial MTC (FMTC) 239, 241, 276 Fat suppression 196 FDG 184 Fertility 114 Fine needle aspiration biopsy 74 - DNA cytometry 37 - Ki ultrasound guidance 75 Flowvoid 195 Fluorodeoxyglucose F-fluorodeoxyglucose C 8 F-FDG) 170, fluorouracil 143,144 FMTC (familial MTC) 239, 241, 276 Foci of uptake 169 Follicular carcinoma 29 Follicular neoplasia 76 Follicular thyroid cancer, risk factors 167 Follicular thyroid carcinoma 82 Follicular thyroid neoplasm 165 Follow-up 186 Frozen section 36 Furosemide 112 G Gardner's syndrome 58 Gene therapy 147 Genetic testing 244, 245 Genetics -MEN 40 - ret proto-oncogene activation 41 German multicenter study 184 Germline mutation 241, 244 Ghosting 200 GLUT1 184 Glutathione, alterations 146
3 Subjext Index 297 Glutathione S-transferase, alterations 146 Goiter multinodular 210 H Hematoxicity 115 Hemodialysis 100 Hemorrhage 217 Hereditary tumor 241 Histological subtypes 34 - encapsulated type 34 - tall-cell variant 35 - widely invasive type 34 Hoarseness 70,81 Human recombinant (hr) TSH 168 Human thyrotropin, recombinant 108 Hiirthle cell 82, 176, 183 Hiirthle cell carcinoma of the thyroid 5, 8; 9, 12 Hyperparathyroidism 244, 245, MEN 2A-MTC MEN2B primary 246, 292 Hyperplasia, reactive 218 Hypofunctionality 73 Hypoparathyroidism 81 I 131I age-related effects doses postoperative therapy therapy 229 ICAM-1 (intercellular adhesion molecule-1) 156 Imaging - after therapeutic dose cross-sectional delayed presurgical sequences imaging, artifacts metaiodobenzylguanidine (MIBG) 176, I-MIBG 258 Immunoscintigraphy 261 Incidence - of anaplastic carcinoma of the thyroid 14 - in childhood and adolescence 8, 9, 17 - of histological subtypes 8, 9, 18,20 - of thyroid cancer 4-8, 16-18,20 Index cases 245 Infertility In-pentetreotide In-pentetreotide ( octreotide), somatostatin receptors 170 Insular thyroid carcinoma (see also poorly differentiated thyroid carcinoma) 82 Intercellular adhesion molecule-! (ICAM-1) 156 International Classification of Disease (ICD) 4 Invasion and metastasis - mechanism 42 - met oncogene 42 Invasive growth 71 In-vitro anti-tumor effects 145 Iodine - dietary intake 56 - intake and thyroid cancer 6, 13, radioactive deficiency 69 Ionising radiation, lack of 193 Iron oxide particles, ultrasmall superparamagnetic 198 JNIH-ABCC Live Span Study in Japan 12 L Laryngeal nerve, recurrent 81 Laryngoceles 220 Latency times 231 Leukemia 116 Levothyroxine (L-T4) 108, 133 Lithium 111 L-T4 (Levothyroxine) 108, effectiveness of the therapy remission risk of tumor progression risk of tumor recurrence suppressive dose minimal possible suppressive therapy - - heart life-long therapy side effects ultrasensitive assays for TSH determination 134 Lung fibrosis 232 Lymph node compartment 277 Lymph node enlargement 69 Lymph node metastases 85, 187, 277, 280 Lymph node stage and prognosis 121 f. Lymphadenectomy 86, 277
4 298 Subject Index - cervicocentral compartment cervicolateral compartment mediastinal compartment 278 Lymphatic drainage 207 M Mit quotient 217 Magnetic resonance imaging 256 Magnetic vector 194 Magnetization 194 Malformation, congenital ll5 Malignancy, risk 69 Marfanoid habitus 247 MDR (multidrug resistance) 145 Mediastinal compartment 278 Medullary (C-cell) carcinoma 31 Medullary thyroid cancer (MTC, see also C-cell carcinoma of the thyroid) 165, 177, 239,251 - calcitonin carcinoembryonic antigen FMTC proto-oncogene RET 275 Melphalan 141, 143 MEN MEN 2A 239, 241, 242, 245, 276 MEN 2B 239, 241, 243, 247, 276 Metastases - bone metastases brain metastases distant 86, lung metastases 102, lymph node metastases pulmonary to the thyroid 15 MIBI 182, 183, 188 Microcarcinoma 98 Micrometastases 85, 86 Mitoxantrone 143, 149 MNG1 59 Mortality 4, 7, 9, 19,20 MRI 77 MTC (medullary thyroid carcinoma) 165, 177,239,251 - chemotherapy clinical presentation of sporadic 243 diarrhea familial hereditary 239, 240, histological appearance lymph nodes metastases 240, palliative therapy radioactive iodine 290 -sporadic 239,243, natural history prognostic factors survival tumor stage 287 MTS-1 60 Mucosalneuromas 247 Multicenter studies on childhood thyroid cancer 231 Multidrug resistance (MDR) MRPl-mediated 147 Multiple endocrine neoplasia, type Multiple endocrine neoplasie (MEN) type 2 syndrome 239 N Na+/K+pump 181 National Cancer Database of the U.S. 3, 8, 9, 17 National Cancer Institute 148 Neck compartment 203 Neck, X-ray 77 Neoplasia, follicular 76 Neoplasm, follicular thyroid 165 Nerve palsy, recurrent 220 Nodule - cold 73 - solitary 69 - thyroid 69 Ntrkl proto-oncogene 59 Nuclear weapon tests 16 0 Occult disease 252 Octreotide Ill, 170,173,185,190,281,291 - somatostatin receptor 172 p Pacemaker, cardiac 199 Papillary carcinoma - ground glass nuclei 28 - occult sclerosing 29 - onocytic cell 29 Papillary microcarcinoma 5, ll, 12 Papillary thyroid cancer 76, 82 - prognosis 167 Papillary tumors 165 Parafollicular C cell 251 Paramagnetic effect 197 Parathyroid dysfunction ll7 Pentagastrin stimulation 245, 290 Pentagastrin test 241
5 Subject Index 299 Peutz-Jegher's syndrome 58 Pheochromocytoma 244,245,276,291 - MEN 2A-MTC MEN2B 276 Polyposis, adenomatous familial 58, 59 Positron emission tomography 170,261 Power-Doppler 71 Pregnancy 115 Presurgical staging 252 Prevalence 6, 8, 11, 12, 20 Primary hyperparathyroidism (see hyperparathyroidism, primary) Proapoptotic pathways 160 Prognosis 82, 122, of anaplastic thyroid carcinoma 9, 10, 14 - of C-cell carcinoma of the thyroid 9, 10, 14 - of histological subtypes 9, 10 - ofhiirthle cell carcinoma 9, 12 - of papillary microcarcinoma 12 - of poorly differentiated thyroid carcinoma 13 - of tall-cell variant of papillary carcinoma 12 - of thyroid cancer in general 5, 7, 9, 10, 18, 19 Prognostic scores 32 Protocol diagnostic treatment 230 Proton density 195 Proto-oncogenes 145 Psychological support 282 PTEN 59 Pulmonary fibrosis 116 Pulmonary metastases, disseminated 232 R Radiation therapy - external 69, 176,281 Radiation thyroiditis 112 Radioiodine 167, amount dose negative thyroid cancer postoperative evaluation side effects uptake whole body scans 175 Radioiodine ablation 94 - activity 95, 97 - dosimetry 95 - microcarcinoma 98 - recurrence 93 - stunning effect 97 - survival rates 93 - thyroid remnant 94 Radioiodine scanning activity false-positive scans 111, stunning effect 110 Radioiodine therapy 99, bone metastases locally invasive thyroid cancer lung metastases 102, lymph node metastases negative radioiodine scan 99, recurrence 93 - side effects survival rates 93 - urinary iodine 100 Radiosensitizer 107 Radiotherapy 106,107 - bone metastases external hyperfractionated 143, locally invasive thyroid cancer 107 Reactor accident, age 229 Receptor tyrosine kinase 241 Recurrence 187 Redifferentiation 153 -therapy 111,187 Relaxation 194 Reoperation - CEA Genotype-phenotype 280 Repetition time 195 Residual thyroid tissue 168 Resonance frequency 194 Response 159 RET proto-oncogene 14, 59, mutation 242 Retinoic acids 111, 153 Retinoids 153 Reverse-transcriptase polymerase chain reaction (RT-PCR) 146 Risk coefficient 231, 225 RT-PCD (reverse-transcriptase polymerase chain reaction) 146 s Salivary gland atrophy 220 Scanning (see Radioiodine scanning) Scars 208 Scintigraphy
6 300 Subject Index - 3D-display of color-doppler. ultrasound 73 - Tc-99m-pertechnetate 71 Scores, prognostic 32 Secondary thyroid carcinomas (see metastases to the thyroid) Serum calcitonin 78 Sialadenitis 113 Single photon emission tomography 170 Small-cell carcinoma of the thyroid 5 Sodium/iodide symporter (NIS) 155 Solid lesion, hypoechogenic 70 Somatic mutation 243, 244 Somatostatin 140, 185,251 - receptor scintigraphy 261 Spatial resolution 188 SPECT 188 Spermatogenesis 114 SPIR 197 Steam cells 115 STIR 197 Stunning effect 97, 110, 169 Support, psychological 282 Surgery, probe-guided 101 Surgical approach, appropriate 177 Surgical resection - complete local extent 166 Surgical therapy - lymph node dissection lymph node staging thyroidectomy 121 Surgical treatment 83 Surveillance, Epidemiology and Emd Results (SEER) programm of the U.S. 9, 10, 16 Survival rates 9, 10, 12, 14, 15, 17-19,247 T { 99 mtc)-sestamibi 170, mTc-tetrofosomin mTc (V)-dimer captosuccinic acid mT-(V)-DMSA 258 2mT1 170,171,176 - chloride 258 T1 time 195 T2 time 195 Tall-cell variant of papillary carcinoma 5, 12, 13 Tamoxifen 111 Taste dysfunction 113 reo 59 Tetrofosmin 182 Thallium 181 Therapy (see Radioiodine therapy) Thyrogen 108 Thyroglobulin marker for the presence of thyroid tissues sensitivity 171 Thyroid adenoma 186 Thyroid cancer 131, apoptosis assessing the risk chemotherapy dilemmas in the follow-up Doxorubicin F-FDG 73 - findings/symptoms 69 - follow-up of differential 73 - hoarseness 81 - hypoparathyroidism Inal 73 - in children prognosis lifetime risk 57 - medullary postoperative evaluation prevalence/risk assessment 69 - radiation-induced radioiodine-negative recurrentlaryngeal nerve 81 - relative incidence Tc-99m-MIBI 73 - therapy for recurrent/metastatic Tl-201 chloride 73 Thyroid carcinoma cell line iodide metabolism iodide uptake 155 Thyroid carcinoma - anaplastic chemoresistance multimodal approach poorly differentiated 5, 9, 13 Thyroid cell proliferation - cancer-related mortality recurrence rate serum thyroglobulin (Tg) 133 Thyroid gland 83 Thyroid hormone replacement 174, 175 Thyroid hormone treatment 131 Thyroid lymphoma 5, 14, 15 Thyroid nodules 69 Thyroid remnants, ablation 172, 177 Thyroid stimulating hormone 167
7 Subject Index 301 Thyroid, mean dose 228 Thyroidectomy 83, 84, 144, completion 87 - prophylactic 245 TNM 5,11 Transmembrane protein 145 Treatment -protocol 143,230 - results 230 Triiodothyronine 108 TSH - human recombinant receptor secretion suppression 133, 175 Tumor aggressiveness - distant metastases lymph node metastases 229 Tumor growth 140 Tumor invasion 210 Tumor marker thyroglobulin 77 Tumor mass reduction 140 Tumor progression 159 Tumor staging 228 u Ultrasonography 70, 256 Ultrasound guidance 75 Undifferentiated thyroid carcinoma 82, 84, 148 Union International Contre Cancer (UICC) 5, 11 USA, incidence 227 v Venous catheterization 288 Vincristine 141, 142, 143 Vitamin A - RA responsive elements (RAREs) retinoid receptors 154 X Xerostomia 113 X-radiation during childhood 16, 19 X-ray 256 X-ray of the neck 77
Thyroid Cancer. With 51 Figures and 30 Tables. Springer
H.-J. Biersack F. Griinwald (Eds.) Thyroid Cancer With 51 Figures and 30 Tables Springer PART 1 Basics 1 The Changing Epidemiology of Thyroid Cancer 3 R. GORGES 1.1 Basic Epidemiological Problems in Thyroid
More informationCalcitonin. 1
Calcitonin Medullary thyroid carcinoma (MTC) is characterized by a high concentration of serum calcitonin. Routine measurement of serum calcitonin concentration has been advocated for detection of MTC
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationIndex. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACC. See Adrenal cortical carcinoma. Acromegaly and the pituitary gland, 551 Acute suppurative thyroiditis, 405, 406 Addison, Thomas and
More informationTHYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine
THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?
More information- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer
Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.
More informationDifferentiated Thyroid Cancer: Initial Management
Page 1 ATA HOME GIVE ONLINE ABOUT THE ATA JOIN THE ATA MEMBER SIGN-IN INFORMATION FOR PATIENTS FIND A THYROID SPECIALIST Home Management Guidelines for Patients with Thyroid Nodules and Differentiated
More informationINDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY
ENDOCRINE SURGERY INDEX Note: Page numbers of issue and article titles are in boldface type. Adenylate cyclase, in signal transduction 425-426 Adrenal incidentalomas, 499-509 imaging of, 502-504 in patients
More information4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.
Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationThyroid carcinoma. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec.
Thyroid carcinoma Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec. Thyroid tumors PRIMARY TUMORS Tumors of the follicular epithelium : - Tumors of the follicular
More informationPEDIATRIC Ariel Katz MD
PEDIATRIC Ariel Katz MD Dept. Otolaryngology Head &Neck Surgery Wolfson Medical Center Holon, Israel OBJECTIVES Overview/Background Epidemiology/Etiology Intro to Guidelines Workup Treatment Follow-Up
More informationImaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist
Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging Deepa R Biyyam, MD Attending Pediatric Radiologist Imaging in Pediatric Thyroid disorders: Imaging modalities Outline ACR-SNM-SPR guidelines
More information2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines
2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results
More informationPersistent & Recurrent Differentiated Thyroid Cancer
Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationOncogenes/Growth Factors & Environment
Oncogenes/Growth Factors & Environment 8 th Postgraduate Course in Endocrine Surgery Crete, Greece September, 2006 Orlo H. Clark M.D. Thyroid Cancer Thyroid cancer is the 8 th most common and most rapidly
More informationManagement guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007
Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung
More informationEvaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
More informationReoperative central neck surgery
Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University
More informationThyroid Nodules. Family Medicine Refresher Course Geeta Lal MD, FACS April 2, No financial disclosures
Thyroid Nodules Family Medicine Refresher Course Geeta Lal MD, FACS April 2, 2014 No financial disclosures Objectives Review epidemiology Work up of Thyroid nodules Indications for FNAB Evolving role of
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationThyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary
Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with
More informationWhat you need to know about Thyroid Cancer
What you need to know about Thyroid Cancer This booklet has been designed to help you to learn more about your thyroid cancer. It covers the most important areas and answers some of the frequently asked
More informationNuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine
Nuclear Medicine Head and Neck Region Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Thyroid scintigraphy Parathyroid scintigraphy F18-FDG PET examinations in head and neck cancer
More informationB Berry, J. 25 see also suspensory ligament of Berry biopsy see fine-needle aspiration biopsy (FNAB); open wedge biopsy
174 Index Index Page numbers in italics refer to illustrations A abscess 80, 137 adenoma 61 parathyroid 18, 18 19, 62, 84 differential diagnosis 84, 84, 85, 85 thyroid 63 follicular 62, 63, 64 macrofollicular
More informationThyroid and Parathyroid Cancers
Thyroid and Parathyroid Cancers Overview Endocrine malignancies, although relatively uncommon, are often difficult to diagnose and treat effectively. This chapter will focus on thyroid and parathyroid
More informationCANCERS OF THE ENDOCRINE ORGANS RARE THYROID CANCERS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES
CANCERS OF THE ENDOCRINE ORGANS RARE THYROID CANCERS PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Giuseppe COSTANTE (Endocrinology, Institut Jules Bordet), Ahmad AWADA (Medical
More informationThyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.
ORIGINAL ARTICLE Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma. Md. Sayedur Rahman Miah, Md. Reajul Islam, Tanjim Siddika Institute of Nuclear Medicine & Allied Sciences,
More informationIndex. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 15 (2006) 681 685 Index Note: Page numbers of article titles are in boldface type. A Ablative therapy, for liver metastases in patients with neuroendocrine tumors, 517 with radioiodine
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationTo the Patient and Family This booklet has been written for people who have received a diagnosis of thyroid cancer or who are being tested for this illness. If you have questions that are not answered
More informationA Review of Differentiated Thyroid Cancer
A Review of Differentiated Thyroid Cancer April 21 st, 2016 FPON Webcast Jonn Wu BMSc MD FRCPC Radiation Oncologist, Vancouver Centre Chair, Provincial H&N Tumour Group, BCCA Clinical Associate Professor,
More information3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women
Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica
More informationThyroid Cancer: Imaging Techniques (Nuclear Medicine)
Thyroid Cancer: Imaging Techniques (Nuclear Medicine) Andrei Iagaru, MD MIPS Molecular Imaging Program at Stanford Stanford University School of Medicine Department of Radiology Introduction Ø There are
More informationManagement of Thyroid Nodules
Management of Thyroid Nodules 38 y/o female with solid 1.5 cm right Thyroid nodule. TSH=0.68 Vincent J. Reid, MD., FACS Thyroid Cancer Incidence & Mortality 1974 to 2004 Overall Women Men Mortality 1 Cancer
More informationThyroid Cancer: When to Treat? MEGAN R. HAYMART, MD
Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK
More informationCabozantinib for medullary thyroid cancer. February 2012
Cabozantinib for medullary thyroid cancer February 2012 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a definitive
More informationNEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa
NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS BY: Shifaa Qa qa Neoplasmas of the thyroid thyroid nodules Neoplastic ---- benign, malignant Non neoplastic Solitary nodules ----- neoplastic Nodules
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationAustin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)
Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide) Overview Indications I-131 therapy for Thyroid Cancer, of the papillo-follicular type, is
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationReview Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update
Bangladesh J Otorhinolaryngol 2010; 16(2): 126-130 Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Md. Abdul Mobin Choudhury 1, Md. Abdul Alim Shaikh
More informationReview Article Management of thyroid carcinoma Alauddin M, Joarder AH
Management of thyroid carcinoma Alauddin M, Joarder AH The ORION Medical Journal 2004 May;18:163-166 Overview The two most common forms of thyroid cancer, papillaryand follicular thyroid cancer, together
More informationTHYROID CANCER IN CHILDREN
THYROID CANCER IN CHILDREN Isabel ROCA, Montserrat NEGRE Joan CASTELL HU VALL HEBRON BARCELONA EPIDEMIOLOGY ADULTS males 1,2-2,6 cases /100.000 females 2,0-3,8 cases /100.000 0,02-0,3 / 100.000 children
More informationCase 4: Disseminated bone metastases from differentiated follicular thyroid cancer
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Disseminated bone
More informationDistant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination
Endocrine Journal 2008, 55 (5), 889 894 Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination YASUHIRO ITO, TOMONORI
More information42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%
Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake
More informationGoiter, Nodules and Tumors
Goiter, Nodules and Tumors Howard J. Sachs, MD www.12daysinmarch.com Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Anaplastic Medullary MEN
More informationThyroid Cancer (Carcinoma)
Information for Patients Thyroid Cancer (Carcinoma) Prepared by the American Association of Clinical Endocrinologists (AACE), a not-for-profit national organization of highly qualified specialists in hormonal
More informationChapter 14: Thyroid Cancer
The American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Presents... Chapter 14: Thyroid Cancer Daiichi Pharmaceutical Corporation, marketers and distributors of FLOXIN Otic (ofloxacin
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationDr J K Jekel Dept. Surgery University of Pretoria
Dr J K Jekel Dept. Surgery University of Pretoria No Maybe ( T`s and C`s apply ) 1. Total thyroidectomy 2. Neck dissection only if nodes are involved 3. Ablative dose or doses of Radioactive Iodine 4.
More informationRossella Elisei. Department of Endocrinology, University Hospital, Pisa, Italy
Rossella Elisei Department of Endocrinology, University Hospital, Pisa, Italy THYROID CANCER IS RARE TUMOR AND REPRESENTS ONLY 3.8% OF ALL HUMAN TUMORS All human cancer Thyroid cancer MOST FREQUENT CANCER
More informationThyroid Pathology: It starts and ends with the gross. Causes of Thyrophobia. Agenda. Diagnostic ambiguity. Treatment/prognosis disconnect
Thyroid Pathology: It starts and ends with the gross Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More informationObjectives. 1)To recall thyroid nodule ultrasound characteristics that increase the risk of malignancy
Evaluation and Management of Thyroid Nodules in Primary Care Chris Sadler, MA, PA C, CDE, DFAAPA Medical Science Outcomes Liaison Intarcia Diabetes and Endocrine Associates La Jolla, CA Past President
More information14 Clinical Review Volume 2 No. 1, 2004
14 Clinical Review Volume 2 No. 1, 2004 CLINICAL REVIEW Well-Differentiated Thyroid Carcinoma: A Review of the Available Follow-Up Modalities Taryn Davids, MD Ally P.H. Prebtani, MD ABSTRACT Well-differentiated
More informationReference No: Author(s) Approval date: October committee. September Operational Date: Review:
Reference No: Title: Author(s) Systemic Anti-Cancer Therapy (SACT) guidelines for Thyroid cancer Dr Fionnuala Houghton Consultant Clinical Oncologist & Dr Lois Mulholland Consultant Clinical Oncologist
More information1. Protocol Summary Summary of Trial Design. IoN
1. Protocol Summary 1.1. Summary of Trial Design Title: Short Title/acronym: IoN Is ablative radioiodine Necessary for low risk differentiated thyroid cancer patients IoN EUDRACT no: 2011-000144-21 Sponsor
More informationMEDULLARY THYROID CANCER and RELATED MEN SYNDROMES. Irina Kovatch, MD SUNY Downstate Medical Center Grand Rounds January 26 th, 2012
MEDULLARY THYROID CANCER and RELATED MEN SYNDROMES Irina Kovatch, MD SUNY Downstate Medical Center Grand Rounds January 26 th, 2012 Thyroid Cancer Comprises 95% of all endocrine malignancies and 1.5% of
More informationHow good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status
New Perspectives in Thyroid Cancer Jennifer Sipos, MD Assistant Professor of Medicine Division of Endocrinology The Ohio State University Outline Thyroid Nodules Thyroid Cancer Epidemiology Initial management
More informationApproach to Thyroid Nodules
Approach to Thyroid Nodules Alice Y.Y. Cheng, MD, FRCPC Twitter: @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationThyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis
Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery thyroid nodules occur in 77% of the world s population palpable thyroid nodules occur in about 5% of women and 1%
More informationMandana Moosavi 1 and Stuart Kreisman Background
Case Reports in Endocrinology Volume 2016, Article ID 6471081, 4 pages http://dx.doi.org/10.1155/2016/6471081 Case Report A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in
More informationObjectives. How to Investigate Thyroid Nodules like A Pro
How to Investigate Thyroid Nodules like A Pro Chris Sadler, MA, PA C, CDE, DFAAPA Medical Science Outcomes Liaison Intarcia Diabetes and Endocrine Associates La Jolla, CA Past President ASEPA Disclosures
More informationRESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer
RESEARCH ARTICLE Comparison of Presentation and Clinical Outcome between Children and Young Adults with Jian-Tao Wang 1,2&, Rui Huang 1&, An-Ren Kuang 1 * Abstract Background: The aim of the present study
More informationThyroid Nodule. N. Rojanapithayakorn P. Prasarttong-Osoth
Thyroid Nodule N. Rojanapithayakorn P. Prasarttong-Osoth A Brief History of the Thyroid A Brief History of the Thyroid Fabricius Wharton Von Haller A Brief History of the Thyroid Kendall Enrico Fermi A
More informationAGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS PAPILLARY THYROID CARCINOMA Clinical Any age Microscopic to large Female: Male= 2-4:1 Radiation history Lymph nodes Prognosis
More informationThyroid and Parathyroid Surgery
Med 5 Surgery Refresher Course 2013 2014 Thyroid and Parathyroid Surgery Dr Shirley Liu Resident Specialist Honorary Clinical Assistant Professor Team 2 Surgery Prince of Wales Hospital Case scenario:
More informationPEDIATRIC THYROID MALIGNACY
PEDIATRIC THYROID MALIGNACY Anthony Sheyn MD Assistant Professor of Otolaryngology Head and Neck Surgery University of Tennessee Health Science Center Thyroid nodules 20 per 1000 children nodules in children
More informationOUTLINE. Regulation of Thyroid Hormone Production Common Tests to Evaluate the Thyroid Hyperthyroidism - Graves disease, toxic nodules, thyroiditis
THYROID DISEASE OUTLINE Regulation of Thyroid Hormone Production Common Tests to Evaluate the Thyroid Hyperthyroidism - Graves disease, toxic nodules, thyroiditis OUTLINE Hypothyroidism - Hashimoto s thyroiditis,
More informationWhat is Thyroid Cancer? Here are four types of thyroid cancer:
What is Thyroid Cancer? Thyroid cancer is a group of malignant tumors that originate from the thyroid gland. The thyroid is a gland in the front of the neck. The thyroid gland absorbs iodine from the bloodstream
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More informationAmerican College of Radiology ACR Appropriateness Criteria
American College of Radiology ACR Criteria Thyroid Carcinoma Variant 1: T1a N0 M0 papillary thyroid cancer: 40-year-old woman. 30 mci with thyrotropin 100 mci with thyrotropin 30 mci with thyroid hormone
More informationMedullary Thyroid Cancer: Medullary Thyroid Cancer
Review & Update Nothing to disclose. Jessica E. Gosnell MD Assistant Professor in Residence Department of Surgery November 9, 2012 Medullary Thyroid Cancer MTC has distinct embryology, genetic association
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationNuclear medicine in endocrinology
Nuclear medicine in endocrinology Thyroid gland: anatomy, function, inflammation, Nuclear medicine in endocrinology tumor dignitiy Parathyroid gland: localisation Adrenal cortex: function Adrenal medulla:
More informationNormal thyroid tissue
Thyroid Pathology Overview Normal thyroid tissue Normal thyroid tissue with follicles filled with colloid. Thyroid cells form follicles, spheres of epithelial cells (always single layered in health, usually
More informationSurgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries
REVIEW ARTICLE J Korean Thyroid Assoc Vol. 4, No. 2, November 2011 Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries Yasuhiro Ito, MD and Akira Miyauchi, MD
More informationWhat is Thyroid Cancer?
Thyroid Cancer What is Thyroid Cancer? The thyroid is a gland at the base of the throat near the trachea (windpipe). It is shaped like a butterfly, with a right lobe and a left lobe. The isthmus, a thin
More information131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans
131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans Anca M. Avram, M.D. Associate Professor of Radiology Department of Nuclear Medicine University of Michigan Ann Arbor,
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationThyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.
Thyroid Gland Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Procedures Cytology (No Accompanying Checklist) Partial Thyroidectomy Total Thyroidectomy With/Without Lymph
More informationWomen s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases
Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases Bill Fleming Epworth Freemasons Hospital 1 Common Endocrine Presentations anatomical problems thyroid nodule / goitre embryological
More informationA CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey
A CASE OF PRIMARY THYROID LYMPHOMA Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey 38 year old female She recognized a mass in her right neck
More informationA rare case of solitary toxic nodule in a 3yr old female child a case report
Volume 3 Issue 1 2013 ISSN: 2250-0359 A rare case of solitary toxic nodule in a 3yr old female child a case report *Chandrasekaran Maharajan * Poongkodi Karunakaran *Madras Medical College ABSTRACT A three
More informationLocally advanced papillary thyroid cancer
Locally advanced papillary thyroid cancer Educational Session 12 th October 2015 Presenters: Smith JA, Carr-Boyd E Supervisors: Palme CE, Elliott M, Navin N, Gupta R Content Case report Imaging Primary
More informationDifferentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment
ORIGINAL ARTICLE Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment Martínez MP, Lozano Bullrich MP, Rey M, Ridruejo MC, Bomarito MJ, Claus
More informationGerard M. Doherty, MD
Surgical Management of Differentiated Thyroid Cancer: Update on 2015 ATA Guidelines Gerard M. Doherty, MD Chair of Surgery Utley Professor of Surgery and Medicine Boston University Surgeon-in-Chief Boston
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: ENDOCRINE 5-May-2013 DEVELOPED BY: Jonathan Serpell
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationNuclear Medicine in Oncology
Radiopharmaceuticals Nuclear Medicine in Oncology Practice Pharmaceutical Radionuc lide Function Tumor type Diphosphonates Tc-99m Osteoblast Bone tumor & metast. Ga-citrate Ga-67 Fe-analogue Bronchogenous
More informationNeoplasia 2018 lecture 11. Dr H Awad FRCPath
Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationPediatric Thyroid Cancer Lung Metastases. Liora Lazar MD
Pediatric Thyroid Cancer Lung Metastases Liora Lazar MD Differentiated thyroid cancer (DTC) The 3rd most common solid tumor in childhood and adolescence Accounting for 1.5%-3% of all childhood cancers
More informationPreoperative Evaluation
Preoperative Evaluation Lateral compartment lymph nodes are easier to detect and are amenable to FNA Central compartment lymph nodes are much more difficult to detect and FNA (Tg washout testing is compromised)
More informationCase 5: Thyroid cancer in 42 yr-old woman with Graves disease
Case 5: Thyroid cancer in 42 yr-old woman with Graves disease Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Thyroid cancer in 42 yr-old woman with
More informationCAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release
CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh
More informationPathology of the Thyroid
Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary
More information